Sondak VK - Search Results

1

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.

Tarhini AA, Lee SJ, Hodi FS, Rao UNM, Cohen GI, Hamid O, Hutchins LF, Sosman JA, Kluger HM, Eroglu Z, Koon HB, Lawrence DP, Kendra KL, Minor DR, Lee CB, Albertini MR, Flaherty LE, Petrella TM, Streicher H, Sondak VK, Kirkwood JM. Tarhini AA, et al. Among authors: sondak vk. J Clin Oncol. 2020 Feb 20;38(6):567-575. doi: 10.1200/JCO.19.01381. Epub 2019 Dec 27. J Clin Oncol. 2020. PMID: 31880964 Free PMC article. Clinical Trial.

2

Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trial.

Flaherty LE, Liu PY, Fletcher WS, Goodwin JW, Balcerzak SP, Daniels D, Stephens RL, Sondak VK. Flaherty LE, et al. Among authors: sondak vk. J Natl Cancer Inst. 1992 Jun 3;84(11):893-4. doi: 10.1093/jnci/84.11.893. J Natl Cancer Inst. 1992. PMID: 1593656 Clinical Trial. No abstract available.

3

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.

Meyskens FL Jr, Kopecky KJ, Taylor CW, Noyes RD, Tuthill RJ, Hersh EM, Feun LG, Doroshow JH, Flaherty LE, Sondak VK. Meyskens FL Jr, et al. Among authors: sondak vk. J Natl Cancer Inst. 1995 Nov 15;87(22):1710-3. doi: 10.1093/jnci/87.22.1710. J Natl Cancer Inst. 1995. PMID: 7473820 Clinical Trial. No abstract available.

4

A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group study.

Sosman JA, Flaherty LE, Liu PY, Fletcher W, Thompson JA, Hantel A, Sondak V. Sosman JA, et al. Invest New Drugs. 1995;13(1):83-7. doi: 10.1007/BF02614226. Invest New Drugs. 1995. PMID: 7499114 Clinical Trial.

5

Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.

Meyskens FL Jr, Liu PY, Tuthill RJ, Sondak VK, Fletcher WS, Jewell WR, Samlowski W, Balcerzak SP, Rector DJ, Noyes RD, et al. Meyskens FL Jr, et al. Among authors: sondak vk. J Clin Oncol. 1994 Oct;12(10):2060-5. doi: 10.1200/JCO.1994.12.10.2060. J Clin Oncol. 1994. PMID: 7931474 Clinical Trial.

6

Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group study.

Fletcher WS, Daniels DS, Sondak VK, Dana B, Townsend R, Hynes HE, Hutchins LF, Pancoast JR. Fletcher WS, et al. Among authors: sondak vk. Am J Clin Oncol. 1993 Aug;16(4):359-62. doi: 10.1097/00000421-199308000-00018. Am J Clin Oncol. 1993. PMID: 8328416 Clinical Trial.

7

The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921).

Flaherty LE, Liu PY, Mitchell MS, Fletcher WS, Walker MJ, Goodwin JW, Stephens RL, Sondak VK. Flaherty LE, et al. Among authors: sondak vk. Am J Clin Oncol. 1996 Apr;19(2):108-13. doi: 10.1097/00000421-199604000-00004. Am J Clin Oncol. 1996. PMID: 8610631 Clinical Trial.

8

Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.

Slavik M, Liu PY, Kraut EH, Natale RB, Flaherty LE, Sondak VK. Slavik M, et al. Among authors: sondak vk. Invest New Drugs. 1995;13(2):143-7. doi: 10.1007/BF00872863. Invest New Drugs. 1995. PMID: 8617577 Free article. Clinical Trial.

9

Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma.

Flaherty LE, Liu PY, Unger J, Sondak VK. Flaherty LE, et al. Among authors: sondak vk. Am J Clin Oncol. 1997 Dec;20(6):600-4. doi: 10.1097/00000421-199712000-00014. Am J Clin Oncol. 1997. PMID: 9391549

10

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study.

Margolin KA, Liu PY, Flaherty LE, Sosman JA, Walker MJ, Smith JW 3rd, Fletcher WS, Weiss GR, Unger JM, Sondak VK. Margolin KA, et al. Among authors: sondak vk. J Clin Oncol. 1998 Feb;16(2):664-9. doi: 10.1200/JCO.1998.16.2.664. J Clin Oncol. 1998. PMID: 9469356 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters